22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has ...

Cellular senescence, where cells permanently stop dividing, plays a complex role in liver health. In a recent review article, ...

Chronic hepatitis C virus (HCV) infection accounts for most cases of hepatocellular carcinoma (HCC) in Japan and is the second major cause in many other countries. Development of HCC takes a ...

A soaring public health concern associated with various risk factors, Hepatocellular carcinoma is particularly a chronic liver disease. In order to combat this rise, awareness and preventive ...

Discover how alcohol consumption exacerbates the risk of cirrhosis and hepatocellular carcinoma by promoting hepatitis B ...

Chronic HBV and HCV infections are the leading causes of hepatocellular carcinoma worldwide ... can significantly reduce viral load and slow disease progression. For HCV, the advent of direct ...

Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...

Hepatocellular carcinoma ... found in people living with chronic viral hepatitis, heavy alcohol use, or metabolic dysfunction-associated steatotic liver disease. This landmark trial demonstrates ...

Thus HCC screening should not be withheld until evidence of active hepatocellular necroinflammation or cirrhosis are observed. Several additional significant clinical-pathologic differences in HCC ...